Publication | Closed Access

A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells

Wild-type P53Rapid Caspase ActivationMedicinePharmacologyCell DeathAnti-cancer AgentTumor SuppressorCancer TreatmentOncologyCell BiologyNovel Bis-benzylidenecyclopentanone DerivativeCancer Research